Bone and Joint Infection
📧 Sign up to get email alerts when something new happens for Bone and Joint Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Clinical Relevance of Intracellular Staphylococci in BOne and Joint Infections
The study examining the clinical relevance of intracellular Staphylococcus in bone and joint infections has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: Comparing Oral Versus Parenteral Antimicrobial Therapy [Phase 4]
Phase 4 clinical trial comparing oral versus parenteral antimicrobial therapy has been terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Tolerability, Safety, and Efficacy of Tedizolid as Oral Treatment for Bone and Joint Infections (OTTER) [Phase 2]
Phase 2 trial evaluating tolerability, safety, and efficacy of oral tedizolid for bone and joint infections has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2022-06-16Clinical Trial Update: Periarticular Penetration of Cefazolin and Clindamycin in Second Stage Revision Arthroplasty of the Hip [Phase 4]
Phase 4 clinical trial assessing periarticular penetration of cefazolin and clindamycin in second-stage revision hip arthroplasty for bone a…
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Pharmacokinetic Variability of Daptomycin During Prolonged Therapy for Bone and Joint Infections
The document reports on pharmacokinetic variability of daptomycin during prolonged therapy for bone and joint infections. It summarizes find…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Teicoplanin-based Antimicrobial Therapy in Staphylococcus Aureus Bone and Joint Infection: Tolerance, Efficacy and Experience With Subcutaneous Administration
A completed clinical trial evaluating teicoplanin-based antimicrobial therapy for Staphylococcus aureus bone and joint infections, focusing …
-
CLINICAL_TRIALS other · 2017-01-04Clinical Trial Update: Lyon BJI Cohort Study
This is an update on the Lyon bone and joint infection cohort trial (NCT02817711) sponsored by Hospices Civils de Lyon; the current status i…
-
FDA approval · 2014-03-05FDA Approved: CIPROFLOXACIN — Original Application (Chartwell RX, LLC)
FDA approved the original application for ciprofloxacin (generic) by Chartwell RX, LLC.